Ids Denmed Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 26-06-2024
- Paid Up Capital ₹ 0.50 M
as on 26-06-2024
- Company Age 18 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 33.78%
(FY 2022)
- Profit -4.91%
(FY 2022)
- Ebitda -12.17%
(FY 2022)
- Net Worth 18.57%
(FY 2022)
- Total Assets 12.06%
(FY 2022)
About Ids Denmed
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Dimple Malhotra, Anju Malhotra, Sanjay Malhotra, and One other member serve as directors at the Company.
- CIN/LLPIN
U33111DL2006PTC148336
- Company No.
148336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
West Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Ids Denmed Private Limited. offer?
Ids Denmed Private Limited. offers a wide range of products and services, including Dentist Tools, Equipment & Supplies, Dental Instruments, Diagnostic Medical Imaging Equipment, X Ray Machine, Autoclaves, Sterilizers & Incubators, Laboratory Autoclave & Sterilizers, Sensors & Transducers, Temperature Sensor, Endodontic Instruments, Dental Equipment.
Who are the key members and board of directors at Ids Denmed?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Praveen Malhotra  | Director | 11-Apr-2006 | Current |
| Dimple Malhotra | Director | 01-Apr-2010 | Current |
| Anju Malhotra | Director | 01-Apr-2010 | Current |
| Sanjay Malhotra | Director | 11-Apr-2006 | Current |
Financial Performance and Corporate Structure Insights of Ids Denmed.
Ids Denmed Private Limited., for the financial year ended 2022, experienced significant growth in revenue, with a 33.78% increase. The company also saw a slight decrease in profitability, with a 4.91% decrease in profit. The company's net worth Soared by an impressive increase of 18.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ids Denmed?
In 2022, Ids Denmed had a promoter holding of 93.00% and a public holding of 7.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ids Denmed?
Ids Denmed has a workforce of 52 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ids Denmed, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ids Denmed's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
